DelveInsight's "VUITY Market Size, Forecast, and Market Insight Report" highlights the details around VUITY, which is a ...

To assess visual performance and overall satisfaction with EDOF CLs, Kamiya and colleagues conducted a prospective study in 42 eyes of 21 subjects with presbyopia. They assessed visual acuity at ...

LENZ Therapeutics, Inc.'s LNZ100 eye drops show strong phase 3 results for presbyopia, outperforming competitors. Click here ...

Phakic IOL technologies have undergone substantial improvements in recent years, with progressive upgrades in design and material and more accurate sizing strategies.At the ESCRS winter meeting, Erik ...

VUITY, an FDA-approved eye drop for presbyopia, has significant market potential given the growing aging population. With an estimated 128 million Americans affected by presbyopia, VUITY offers ...

Alcon introduces Clareon PanOptix Pro IOL to select practices across the United States, with commercial availability expected ...

American Century Companies Inc. boosted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 0.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 45,210 ...

New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025 Upon FDA approval, commercial launch activities to commence immediately with ...

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the ...

In today’s digitally driven world, the average person spends a significant portion of their day looking at screens—phones, ...

ALC secures CE Mark for Clareon Vivity IOL, bringing advanced presbyopia-correcting lens technology to Europe, enhancing ...

Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities ...